RecruitingNCT04477889
Methodist Health System COVID-19 Patient Registry
Sponsor
Methodist Health System
Enrollment
500 participants
Start Date
Jun 20, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patient tested positive for COVID-19 (SARS-CoV-2)
- Patient sought care for COVID-19 at a MHS facility
- Aged 18 years or older
Exclusion Criteria3
- Patient that do not have COVID-19
- Non-confirmed COVID-19 patients
- Aged 17 years or younger
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERTreatment for COVID-19
Patients treated for COVID-19
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04477889
Related Trials
A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
NCT072211628 locations
International Survey of Acute Coronavirus Syndromes-COVID-19
NCT051886122 locations
Impact of the Coronavirus (COVID-19) on Patients With Cancer
NCT043305211 location
Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults
NCT071837093 locations
Arginine Replacement Therapy in COVID-19
NCT058553301 location